HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.

Abstract
Local and lymphnodal recurrences of medullary thyroid carcinoma (MTC) in thyroidectomy patients with elevated plasma levels of calcitonin and/or CEA can be detected using 111In-pentetreotide (Octreoscan: OCT) scintigraphy, although the sensitivity of this technique in localizing an intrathyroid recurrence of tumor is affected by the low target/non-target uptake ratio. The survival rate of patients with MTC, who have undergone thyroidectomy and who show evidence of a rise in plasma levels of calcitonin and/or CEA is closely linked to the number and localization of the metastases. However the role of conventional imaging techniques (X-rays, US, CT, and MR) in the follow-up after thyroidectomy is controversial. Numerous radiocompounds are currently being used to detect local and distant recurrences of MTC. The present study evaluated OCT and pentavalent 99mTc-dimercapto-succinic-acid (99mTc-DMSA-V) scintigraphy performed in 13 patients with a histologic diagnosis of MTC and in one with MEN 2A, all of whom had undergone thyroidectomy between 3 months and 15 years before. The patients also underwent 123I (NaCI) scintigraphy to evaluate the sites and extension of thyroidal remnants. 111In-pentetreotide scintigraphy was positive in 9/14 patients (64%); the 99mTc-DMSA-V was positive in 5/14 patients (35%). 111In-pentetreotide scintigraphy recognized 18 sites of abnormal uptake (12 in the neck); 9mmTc-DMSA-V detected 9 MTC recurrences in the same patients. In conclusion, 111In-OCT scintigraphy represents, in the authors' experience, a useful method, more sensitive than 9mmTc-DMSA-V, to detect MTC recurrences in patient follow-up post-thyroidectomy.
AuthorsL Celentano, P Sullo, M Klain, G Lupoli, E Cascone, M Salvatore
JournalThe quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) (Q J Nucl Med) Vol. 39 Issue 4 Suppl 1 Pg. 131-3 (Dec 1995) ISSN: 1125-0135 [Print] Italy
PMID9002771 (Publication Type: Journal Article)
Chemical References
  • Carcinoembryonic Antigen
  • Indium Radioisotopes
  • Iodine Radioisotopes
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Somatostatin
  • Calcitonin
  • Succimer
  • pentetreotide
Topics
  • Adult
  • Aged
  • Calcitonin (blood)
  • Carcinoembryonic Antigen (blood)
  • Carcinoma, Medullary (diagnostic imaging, secondary, surgery)
  • Diagnostic Imaging
  • Female
  • Follow-Up Studies
  • Humans
  • Indium Radioisotopes
  • Iodine Radioisotopes
  • Lymphatic Metastasis (diagnostic imaging)
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 2a (diagnostic imaging)
  • Neoplasm Recurrence, Local (diagnostic imaging)
  • Organotechnetium Compounds
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Somatostatin (analogs & derivatives)
  • Succimer
  • Survival Rate
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Thyroid Neoplasms (diagnostic imaging, surgery)
  • Thyroidectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: